Consultation Hotline

+1 (302) 618-8777

Related Services: Shimadzu ,Agilent ,Sciex ,Waters ,LCMS ,Thermo ,Waters

Current location:Home > Blogs > Industry News

China Introduces Government Procurement Restrictions on 46 U.S. Companies, While Exempting U.S.-Invested Enterprises Operating in China

Release time:2026/11/12 Click count:278

June 22, 2026 | Beijing, China

China has introduced new measures affecting government procurement from 46 U.S. companies, marking another important development in the country's government procurement policies and international business environment. The Ministry of Finance issued a notice titled Measures Regarding Relevant U.S. Companies in Government Procurement Activities, identified as Caiku [2026] No. 10, on June 22, 2026.

Although the document contains only a few provisions, its implications for government procurement, international suppliers, and multinational corporations operating in China are significant.

1. New Government Procurement Restrictions Cover 46 U.S. Companies

According to the official notice issued by China's Ministry of Finance, government procurement purchasers are prohibited from purchasing products manufactured by the 46 U.S. companies identified in the accompanying list.

The measure took effect immediately upon issuance on June 22, 2026.

The notice applies to government procurement activities involving central government budget units and local government procurement authorities. It establishes a specific procurement restriction covering the products manufactured by the listed companies.

The policy represents an important development for international businesses supplying equipment, technology, and other products to China's government procurement market.

For companies participating in public procurement projects, reviewing supplier qualifications, product origins, manufacturing arrangements, and supply chain structures will become increasingly important.

2. U.S.-Invested Enterprises in China Are Excluded

One particularly important provision of the notice is its explicit exclusion of U.S.-invested enterprises operating in China.

The document states that the procurement restriction applies to products manufactured by the 46 listed U.S. companies, excluding U.S.-invested enterprises in China.

This distinction is significant for multinational corporations that maintain manufacturing facilities, subsidiaries, or joint ventures in the Chinese market.

It means that the policy does not establish a blanket prohibition on all products associated with American technology or American investment.

Instead, the distinction between products manufactured by the listed U.S. companies and those produced by U.S.-invested enterprises in China remains important.

For multinational manufacturers, localized production and clearly documented manufacturing arrangements may therefore remain relevant to their participation in eligible government procurement activities.

However, companies should not automatically assume that every locally manufactured product qualifies for the exclusion. Actual corporate structures, manufacturing entities, and applicable procurement requirements must be carefully verified.

3. Potential Impact on Laboratory Equipment and Scientific Research

The policy may attract particular attention from China's laboratory equipment, pharmaceutical, biotechnology, and scientific research industries.

Many Chinese laboratories use analytical instruments and scientific equipment supplied by international manufacturers. These products include high-performance liquid chromatography systems, gas chromatographs, mass spectrometers, inductively coupled plasma instruments, flow cytometers, centrifuges, and molecular biology equipment.

For government-funded laboratories and public research institutions, procurement teams may need to review whether a proposed product falls within the scope of the newly issued restrictions.

Equipment manufacturers, distributors, and laboratory service providers should also pay attention to product manufacturing origins and the identity of the actual manufacturing entity.

For the used laboratory instrument market, procurement eligibility should be assessed individually rather than determined solely by brand ownership or the country where a company's headquarters is located.

4. Opportunities for Localized Manufacturing and Supply Chains

The exclusion of U.S.-invested enterprises in China highlights the importance of localized manufacturing arrangements.

Over the past several decades, many international manufacturers have established production facilities, research centers, and supply chain partnerships in China.

These operations have contributed to local employment, industrial development, technology exchange, and the expansion of domestic manufacturing capabilities.

Under the distinction established by this notice, products manufactured by qualifying U.S.-invested enterprises in China are not included in the stated restriction simply because of their American investment background.

This may encourage companies to pay closer attention to their manufacturing locations, legal entities, and supply chain transparency.

For international businesses, maintaining a clear distinction between headquarters, subsidiaries, joint ventures, and actual manufacturing operations will become increasingly important when evaluating government procurement opportunities.

5. Compliance and Market Adaptation

The new measure also highlights the importance of procurement compliance for suppliers operating in China.

Companies should carefully examine the official list of 46 U.S. enterprises attached to the notice, verify the manufacturing origin of their products, and review the eligibility requirements of individual procurement projects.

Government procurement purchasers and suppliers should maintain accurate documentation to support product identification and compliance assessments.

It is equally important to distinguish government procurement restrictions from general commercial transactions. The notice specifically addresses government procurement activities and should not automatically be interpreted as a nationwide ban on all commercial purchases of products from the listed companies.

6. Looking Ahead

China's Caiku [2026] No. 10 notice introduces a specific restriction on products manufactured by 46 listed U.S. companies in government procurement, while expressly excluding U.S.-invested enterprises in China.

For international manufacturers, distributors, laboratory equipment suppliers, and technology companies, understanding the distinction between corporate ownership, manufacturing origin, and procurement eligibility will be essential.

As global supply chains continue to evolve, companies that maintain transparent manufacturing arrangements, diversified sourcing strategies, and strong regulatory compliance systems will be better positioned to adapt to changes in China's procurement environment.

The development also reinforces the growing importance of localized production and supply chain transparency in international business operations.